Jay Shepard - 23 May 2024 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Reporting relationship: Director
Issuer ticker: ESPR
Reported as of: 23 May 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 May 2024, 16:14:36 UTC
Prior SEC filing: 22 May 2024
Next SEC filing: 21 Jun 2024
Source filing: View source filing
Reporting owner signature: /s/ Sheldon L. Koenig, by power of attorney

Key filing fact

Jay Shepard filed Form 4 for Esperion Therapeutics, Inc. (ESPR) on 24 May 2024.

Key facts

This page summarizes Jay Shepard's Form 4 filing for Esperion Therapeutics, Inc. (ESPR).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 24 May 2024, 16:14.

Change

Previous filing in this sequence was filed on 22 May 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ESPR transaction

Common Stock

Award

Transaction value: $0
Shares: +23,000
Change %: +80%
Price: $0.000000
Shares after: 51,599
Date: 23 May 2024
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ESPR transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +32,500
Change %
Price: $0.000000
Shares after: 32,500
Date: 23 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 32,500
Exercise price: $2.25
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The awards vest in full on the earlier of (i) May 23, 2025 and (ii) the Issuer's next annual meeting of stockholders following May 23, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .